KANSAS CITY, Mo. — A worldwide coronavirus vaccine trial that included two Kansas City-area hospitals as test sites has been paused.
The AstraZeneca trial, which was set to include the University of Kansas and Children's Mercy as sites, is on a "temporary hold" to determine if a side effect that a participant had was related to the vaccine, according to an Associated Press report.
That participant was not affiliated with KUMC or Children's Mercy's trial sites.
A spokesperson with KUMC confirmed to 41 Action News the stall in the trial's progress.
Oxford University developed the vaccine in the AstraZeneca trial.
Sites throughout the U.S. were expected to conduct trials with roughly 1,500 participants each, for a total of 30,000 nationwide. More than 60 locations are listed in detailed information about the trial on a clinical trials website.